Alnylam Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript
Hi, everyone. Welcome to the Cowen Healthcare Conference fireside chat with Alnylam. I'm covering analyst, Ritu Baral. And with us today is CEO, John Maraganore, who I'm sure most of you, if not all of you, already know.
Thanks, John, for joining us today.
Questions & Answers
I guess we -- let's kick it off. I think most of the folks who've dialed in don't necessarily need to level set. You've already reported the quarter. You did really well for -- I mean, let's just start there.
ONPATTRO is doing really surprisingly well for every 3-week IV drug during COVID when people don't really want to go out or go into infusion centers, et cetera. What do you believe -- what does your marketing team believe is driving this? And is this -- we're a couple of years out from launch at this point. Is this sustained? Like is this despite
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |